FDA Inspection 1050820 — Ian W Flinn MD, Ph D
The FDA completed an inspection of Ian W Flinn MD, Ph D on April 20, 2018 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nashville, TN (United States)
Additional Details
Clinical Investigator (CI)